- A MiG 21 fighter jet crashes in Kangra district of Himachal Pradesh: Police.
- Govt is ready for discussion on any issue raised by different political parties: PM Modi
- PM Narendra Modi calls for extensive discussion on important issues of national interest
- Two bodies pulled out of rubble of six-storey under-construction building that collapsed
HEALTH & FITNESS
Drug regulator cancels licence for Diclofenac sold by Novartis
India's drug regulator has enforced a ban on the manufacture and sale of painkiller injection, Diclofenac, marketed by Novartis India Ltd, after a Health Ministry panel raised concerns over the medicine's impact on health.
"The DGCI ordered for the cancellation of the manufacturing licence granted to Themis Medicare for Diclofenac sodium injection 75 mg/ml, containing Transcutol-P ...On July 4," a government official said.
The drug controller general of India (DCGI) further ordered for the withdrawal of the drug's stock from the market.
The order came as a shot in the arm for Troikaa Pharmaceuticals Ltd, based in Gujarat, which had claimed that the diclofenac sodium 75mg/ml injection contained Transcutol-P which caused damage to the kidneys.
Diclofenac injection was marketed by Novartis under the brand name Voveran 1ml.
Following allegations by Troikaa, which had approached the Health Ministry to stop the injection's sales, the government had formed a panel to review its safety in 2015. The panel submitted a report favouring Troikaa.
A second committee was formed after Novartis moved the Health Ministry which gave a clean chit to the company prompting Troikaa to approach the Delhi High Court in 2016.
"A third committee was then formed under Girish Sahni, director general, Council of Scientific and Industrial Research (CSIR), in May last year which in its report, submitted in December, backed the claims made by Troikaa," the official said.
The DCGI has directed the state drug controller in Dehradun, Uttarakhand, and the drug licensing authority of Daman and Diu to cancel the license granted to M/s Themis Medicare to manufacture for sale of Diclofenac injection 75 mg/ml containing Transcutol-P, the official said.
- Childhood abuse may up endometriosis risk in adulthood 18 Jul 2018 | IANS
- Scent of coffee may help you crack GMAT: Study 18 Jul 2018 | PTI
- Unhealthy fat, cholesterol linked with lower fertility 17 Jul 2018 | IANS
- Brain area linked to binge eating identified 17 Jul 2018 | IANS
- Can a magnetic wire help early detection of cancer 17 Jul 2018 | IANS
- 4 in 10 Indians unaware of cyberbullying: Study 17 Jul 2018 | IANS
- Childhood infections may affect academic performance 17 Jul 2018 | PTI
- Younger pregnant women at high risk of prenatal depression: Study 17 Jul 2018 | IANS
- Nano bubbles filled with drug may kill cancer cells 16 Jul 2018 | IANS
- Empanelled hospitals to have Ayushman Mitra to assist patients seeking treatment under the scheme 16 Jul 2018 | PTI
Sunday EditionView All
15 Jul 2018 | PTI | New Delhi
Amid row over alleged use of derogatory language in a web series while referring to former Prime Minister Rajiv Gandhi, Congress chief Rahul Gandhi on Saturday said the BJP and the RSS believe that freedom of expression must be policed, while he regards it as a fundamental democratic right. “My father lived and died in the service of India...
STATE EDITIONSView All
18 Jul 2018 | Staff Reporter | RAIPUR
A two-month-old infant died due to suffocation after the door of the ‘108 Ambulance Service’ that was carrying him to a hospital malfunctioned and failed to open on time at Dr Bhimrao Ambedkar Hospital here on Tuesday. The Ambulance operators tried to open the door for a couple of hours but failed to open it on time...